Ubs Ag 424B2 Filing

Risk Assessment

Risk Level: medium

FAQ

Key Financial Figures

• $11,701,000 — ion Statement No. 333-283672 UBS AG $11,701,000 Capped Leveraged Buffered S&P 500 Ind
• $1,193.92 — ect to the maximum settlement amount of $1,193.92 for each $1,000 face amount of your not
• $1,000 — settlement amount of $1,193.92 for each $1,000 face amount of your notes. If the final
• $997.50 — ue of the notes as of the trade date is $997.50 per $1,000 face amount. The estimated i
• $1,000.00 — settlement amount of $1,193.92 for each $1,000.00 face amount of your notes. You can to
• $1,193.92 B — lier level Maximum settlement amount: $1,193.92 Buffer level: 5,780.67875, which is 87.50

Filing Documents

• ubs_424b2-10407.htm (424B2) — 268KB
• ex-filingfees.htm (EX-FILING FEES) — 8KB
• image1.jpg (GRAPHIC) — 12KB
• image2.jpg (GRAPHIC) — 92KB
• image3.jpg (GRAPHIC) — 35KB
• 0001839882-26-016467.txt ( ) — 561KB
• ex-filingfees_htm.xml (XML) — 2KB

From the Filing

Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-283672 UBS AG $11,701,000 Capped Leveraged Buffered S&P 500 Index-Linked Medium-Term Notes due August 18, 2027 The notes do not bear interest. The amount that you will be paid on your notes on the stated maturity date (August 18, 2027) is based on the performance of the S&P 500 Index as measured from the trade date (March 19, 2026) to and including the determination date (August 16, 2027). If the final underlier level on the determination date is greater than the initial underlier level of 6,606.49, the return on your notes will be positive, subject to the maximum settlement amount of $1,193.92 for each $1,000 face amount of your notes. If the final underlier level declines by up to 12.50% from the initial underlier level, you will receive the face amount of your notes. If the final underlier level declines by more than 12.50% from the initial underlier level, the return on your notes will be negative. Specifically, you will lose approximately 1.1429% of the face amount of your notes for every 1% negative underlier return below the buffer level of 87.50% of the initial underlier level. You could lose your entire investment in the notes. To determine your cash settlement amount, we will calculate the underlier return, which is the percentage increase or decrease in the final underlier level from the initial underlier level. On the stated maturity date, for each $1,000 face amount of your notes, you will receive an amount in cash equal to: if the underlier return is positive (the final underlier level is greater than the initial underlier level), the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) the upside participation rate of 160.00% times (c) the underlier return, subject to the maximum settlement amount; if the underlier return is zero or negative but not below -12.50% (the final underlier level is equal to or less than the initial underlier level but not by more than 12.50%), $1,000; or if the underlier return is negative and is below -12.50% (the final underlier level is less than the initial underlier level by more than 12.50%), the sum of (i) $1,000 plus (ii) the product of (a) approximately 114.29% times (b) the sum of the underlier return plus 12.50% times (c) $1,000. Your investment in the notes involves certain risks, including, among other things, our credit risk. See "Additional Risk Factors Specific To Your Notes" beginning on page 9 herein. You should read the additional disclosure herein so that you may better understand the terms and risks of your investment. The estimated initial value of the notes as of the trade date is $997.50 per $1,000 face amount. The estimated initial value of the notes was determined as of the close of the relevant markets on the date hereof by reference to UBS' internal pricing models, inclusive of the internal funding rate. For more information about secondary market offers and the estimated initial value of the notes, see "Additional Risk Factors Specific To Your Notes — Estimated Value Considerations" and "— Risks Relating to Liquidity and Secondary Market Price Considerations" beginning on page 11 herein. Original issue date: March 24, 2026 Original issue price: 100.00% of the face amount Underwriting discount*: 0.00% of the face amount Net proceeds to the issuer*: 100.00% of the face amount * For additional information, see "Supplemental plan of distribution (conflicts of interest); secondary markets (if any)" herein. Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these notes or passed upon the accuracy or adequacy of this document, the accompanying product supplement, the accompanying index supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. The notes are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency. UBS Securities LLC Pricing Supplement dated March 19, 2026 The issue price, underwriting discount and net proceeds listed above relate to the notes we sell initially. We may decide to sell additional notes after the date of this pricing supplement, at issue prices and with underwriting discounts and net proceeds that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the notes will depend in part on the issue price you pay for such notes. UBS Securities LLC, our affiliate, will purchase the notes from UBS for distribution to one or more registered broker dealers ("dealers"). UBS Securities LLC, the dealers or any of their respective affiliates may use this document in market-making transactions in notes after their initial sale. Unless UBS, UBS Securities LLC, the dealers or any of their respective affiliates selling such notes to you informs you otherwise in the confirmation of sale, this pricing supple

View Full Filing

View this 424B2 filing on SEC EDGAR